Loading clinical trials...
Loading clinical trials...
Double-Blind, Placebo-Controlled, Dose-Ranging Study to Determine the Efficacy and Safety of BG00012 in Subjects With Relapsing-Remitting Multiple Sclerosis
Conditions
Interventions
BG00012
Locations
42
Czechia
Faculty Hospital St. Anne
Bmo, Czechia
Faculty Hospital
Hradec Králové, Czechia
Hospital of Pardubice
Pardupice, Czechia
Faculty Hospital of Plzen
Pilsen, Czechia
General Teaching Hospital
Prague, Czechia
Bochum am St. Josef-Hospital
Bochum, Germany
Start Date
October 1, 2004
Primary Completion Date
March 31, 2006
Completion Date
March 31, 2006
Last Updated
August 28, 2023
NCT06276634
NCT07225504
NCT06809192
NCT05359653
NCT07426991
NCT07376772
Lead Sponsor
Biogen
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions